Keck School Faculty

Daniel M. Togasaki, MD, PhD
Daniel M. Togasaki, MD, PhD
Associate Professor of Clinical Neurology
Neurology
HCT 3000 Health Sciences Campus Los Angeles

Dextromethorphan/Quinidine in Migraine Prophylaxis: An Open-label Observational Clinical Study Clin Neuropharmacol. 2018 Mar/Apr; 41(2):64-69. . View in PubMed

CD4 cell response to interval therapy with natalizumab Ann Clin Transl Neurol. 2015 May; 2(5):570-4. . View in PubMed

Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial JAMA Neurol. 2014 Feb; 71(2):141-50. . View in PubMed

Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease Mov Disord. 2013 Jun; 28(6):817-20. . View in PubMed

Caffeine consumption and risk of dyskinesia in CALM-PD Mov Disord. 2013 Mar; 28(3):380-3. . View in PubMed

Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury Neurobiol Dis. 2008 Nov; 32(2):319-27. . View in PubMed

Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury J Neurosci. 2007 May 16; 27(20):5291-300. . View in PubMed

The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates Exp Neurol. 2007 May; 205(1):101-7. . View in PubMed

The Webcam system: a simple, automated, computer-based video system for quantitative measurement of movement in nonhuman primates J Neurosci Methods. 2005 Jun 30; 145(1-2):159-66. . View in PubMed

Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa Neuropharmacology. 2005 Mar; 48(3):398-405. . View in PubMed

Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys Neuroscience. 2005; 132(2):409-20. . View in PubMed

Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys J Pharmacol Exp Ther. 2004 Nov; 311(2):770-7. . View in PubMed

The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys Mov Disord. 2002 Sep; 17(5):902-9. . View in PubMed

Imaging and therapeutics: the role of neuronal transport in the regional specificity of L-DOPA accumulation in brain Mol Imaging Biol. 2002 May; 4(3):208-18. . View in PubMed

Novel observations with FDOPA-PET imaging after early nigrostriatal damage Mov Disord. 2001 Sep; 16(5):838-48. . View in PubMed

Levodopa induces dyskinesias in normal squirrel monkeys Ann Neurol. 2001 Aug; 50(2):254-7. . View in PubMed

Epidemiologic aspects Adv Neurol. 2000; 82:53-9. . View in PubMed

Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture J Neurochem. 1997 Jul; 69(1):21-33. . View in PubMed

Powered by SC CTSI
Go to Top